Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
Clinical trial NCT02118961 · COMPLETED
Trial details
- NCT number
- NCT02118961
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-08-01
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.